{
    "clinical_study": {
        "@rank": "1551", 
        "acronym": "VALTS", 
        "arm_group": [
            {
                "arm_group_label": "intravenous propofol/midazolam", 
                "arm_group_type": "Active Comparator", 
                "description": "Sedation using intravenous propofol/midazolam, sedation will be titrated to a Riker Agitation Sedation Score"
            }, 
            {
                "arm_group_label": "isoflurane", 
                "arm_group_type": "Active Comparator", 
                "description": "Sedation using inhaled isoflurane, sedation will be titrated to a Riker Agitation Sedation Score"
            }
        ], 
        "brief_summary": {
            "textblock": "Heavy sedation or sleep is a common problem within the intensive care unit (ICU) using our\n      standard intravenous medications. This commonly leads to confusion, low blood pressure, slow\n      wake up and removal of the artificial breathing tube (extubation), which prolongs ICU stay.\n      Using inhaled volatile anesthetic agents are likely to improve these patient outcomes. This\n      unique project is the first North American study looking at using volatiles for patients who\n      need longer-term ICU sedation. This project has excellent potential at lowering these\n      complications and improving quality of care, which will lower patient ICU stay and\n      healthcare costs."
        }, 
        "brief_title": "AnaConDa Long Term Sedation Study", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intubated Requiring Sedation for Greater Than 48 Hours", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult ICU patients expected to be ventilated > 48 hours\n\n        Exclusion Criteria:\n\n          -  age < 18 years\n\n          -  history of malignant hyperthermia\n\n          -  propofol infusion syndrome\n\n          -  evidence of raised intracranial pressure\n\n          -  6-month mortality risk from pre-existing condition > 50%\n\n          -  lack of commitment to maximal treatment\n\n          -  pregnant\n\n          -  if on Flolan"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983800", 
            "org_study_id": "UHN 13-5845"
        }, 
        "intervention": [
            {
                "arm_group_label": "isoflurane", 
                "intervention_name": "Isoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "intravenous propofol/midazolam", 
                "intervention_name": "Propofol/midazolam", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Propofol", 
                "Isoflurane"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mechanical Ventilation", 
            "Volatile Sedation", 
            "Intravenous Sedation", 
            "Delirium"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jmacdonald@ottawaheart.ca", 
                    "last_name": "John MacDonald, MD", 
                    "phone": "613-761-4379"
                }, 
                "contact_backup": {
                    "email": "dwinch@ottawaheart.ca", 
                    "last_name": "Denyse Winch"
                }, 
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1Y 4W7"
                    }, 
                    "name": "Ottawa Heart Institute"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "angela.jerath@uhn.ca", 
                    "last_name": "Angela Jerath, MD", 
                    "phone": "416-340-4800", 
                    "phone_ext": "3242"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 2C4"
                    }, 
                    "name": "Toronto General Hospital, University Health Network"
                }, 
                "investigator": [
                    {
                        "last_name": "Angela Jerath, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Marcin Wasowicz, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Niall Ferguson, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Andrew Steel, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Duminda Wijeysundera, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Linda Flockhart, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Vivek Rao, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mazerd@smh.toronto.on.ca", 
                    "last_name": "David Mazer, MD", 
                    "phone": "416-864-5825"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5B 1W8"
                    }, 
                    "name": "St. Michael's Hospital"
                }, 
                "investigator": {
                    "last_name": "David Mazer, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of Volatile Anesthetics for Long-Term Sedation In Critically Ill Patients", 
        "overall_contact": {
            "email": "angela.jerath@uhn.ca", 
            "last_name": "Angela Jerath, MD", 
            "phone": "416-340-4800", 
            "phone_ext": "3242"
        }, 
        "overall_contact_backup": {
            "email": "jo.carroll@uhn.ca", 
            "last_name": "Jo Carroll", 
            "phone": "416-340-4800", 
            "phone_ext": "3243"
        }, 
        "overall_official": {
            "affiliation": "Toronto General Hospital, University Health Network", 
            "last_name": "Angela Jerath, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Daily assessment of atmospheric volatile levels will be measured using photometric multigas infrared analyzer", 
                "measure": "atmospheric volatile concentration", 
                "safety_issue": "Yes", 
                "time_frame": "daily"
            }, 
            {
                "description": "adherence to the volatile sedation, sedation will be guided by explicit protocols targeting a Sedation-Agitation Score (SAS) of 3-4", 
                "measure": "Sedation", 
                "safety_issue": "No", 
                "time_frame": "daily"
            }, 
            {
                "description": "assess rate of patient recruitment and barriers to recruitment", 
                "measure": "Feasibility", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "multidisciplinary feedback regarding teaching package, protocol, quality of sedation", 
                "measure": "Education Tool", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Measurements will be taken 24 hours post sedation and every 48 hours until extubation or 30 days", 
                "measure": "serum fluoride levels", 
                "safety_issue": "Yes", 
                "time_frame": "every 48 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983800"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Health Network, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Health Network, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}